In malignant glioma, treatment with subtoxic doses of daidzein in combination with TRAIL induces rapid apoptosis in glioma cells because daidzein overcomes TRAIL resistance by modulating the expression of the intrinsic apoptotic inhibitor bcl-2 (Siegelin et al., 2009). The gene discussed is BCL2; the disease is central nervous system cancer.